# PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI

> **NCT04045873** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 306 (estimated)

## Conditions studied

- Coronary Artery Disease
- Heart Failure

## Interventions

- **DEVICE:** extracorporeal membrane oxygenation

## Key facts

- **NCT ID:** NCT04045873
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2021-07
- **Final completion:** 2024-06
- **Target enrollment:** 306 (ESTIMATED)
- **Last updated:** 2019-08-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04045873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04045873, "PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04045873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*